Metabolomic fingerprinting: challenges and opportunities.

Systems biology has primarily focused on studying genomics, transcriptomics, and proteomics and their dynamic interactions. These, however, represent only the potential for a biological outcome since the ultimate phenotype at the level of the eventually produced metabolites is not taken into consideration. The emerging field of metabolomics provides complementary guidance toward an integrated approach to this problem: It allows global profiling of the metabolites of a cell, tissue, or host and presents information on the actual end points of a response. A wide range of data collection methods are currently used and allow the extraction of global or tissue-specific metabolic profiles. The great amount and complexity of data that are collected require multivariate analysis techniques, but the increasing amount of work in this field has made easy-to-use analysis programs readily available. Metabolomics has already shown great potential in drug toxicity studies, disease modeling, and diagnostics and may be integrated with genomic and proteomic data in the future to provide in-depth understanding of systems, pathways, and their functionally dynamic interactions. In this review we discuss the current state of the art of metabolomics, its applications, and future potential.

[1]  Jung-Wook Bang,et al.  A metabolic entropy approach for measurements of systemic metabolic disruptions in patho-physiological States. , 2010, Journal of proteome research.

[2]  R. Kaliszan,et al.  Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques , 2010, Electrophoresis.

[3]  F. Wright,et al.  Use of Pharmaco‐Metabonomics for Early Prediction of Acetaminophen‐Induced Hepatotoxicity in Humans , 2010, Clinical pharmacology and therapeutics.

[4]  Q. Zhan,et al.  Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer. , 2010, Journal of proteome research.

[5]  Eytan Ruppin,et al.  Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model , 2010, Bioinform..

[6]  M. Aller,et al.  A Review of metabolic staging in severely injured patients , 2010, Scandinavian journal of trauma, resuscitation and emergency medicine.

[7]  Elaine Holmes,et al.  High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues , 2010, Nature Protocols.

[8]  David S. Wishart,et al.  MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..

[9]  G. Mingrone,et al.  Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype , 2010, International Journal of Obesity.

[10]  J. Utzinger,et al.  Integrated Cytokine and Metabolic Analysis of Pathological Responses to Parasite Exposure in Rodents , 2010, Journal of proteome research.

[11]  Bin Wang,et al.  Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach. , 2009, Journal of proteome research.

[12]  Manuel Desco,et al.  A novel R-package graphic user interface for the analysis of metabonomic profiles , 2009, BMC Bioinformatics.

[13]  H. Keun,et al.  Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy , 2009, Clinical Cancer Research.

[14]  Charles S Henry,et al.  Review: Microfluidic applications in metabolomics and metabolic profiling. , 2009, Analytica chimica acta.

[15]  Bowei Xi,et al.  1H NMR metabolomics study of age profiling in children , 2009, NMR in biomedicine.

[16]  Jeremiah Stamler,et al.  Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation. , 2009, Analytical chemistry.

[17]  David S. Wishart,et al.  MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..

[18]  A. Darzi,et al.  The gut microbiota as a target for improved surgical outcome and improved patient care. , 2009, Current pharmaceutical design.

[19]  F. Jessen,et al.  Association of SORL1 gene variants with Alzheimer's disease , 2009, Brain Research.

[20]  Alexey V Antonov,et al.  TICL – a web tool for network‐based interpretation of compound lists inferred by high‐throughput metabolomics , 2009, The FEBS journal.

[21]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[22]  Jens Stoye,et al.  MeltDB: a software platform for the analysis and integration of metabolomics experiment data , 2008, Bioinform..

[23]  David S. Wishart,et al.  MetaboMiner – semi-automated identification of metabolites from 2D NMR spectra of complex biofluids , 2008, BMC Bioinformatics.

[24]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[25]  Ara Darzi,et al.  The human gut microbiome: Implications for future health care , 2008, Current gastroenterology reports.

[26]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[27]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[28]  Karsten Suhre,et al.  MassTRIX: mass translator into pathways , 2008, Nucleic Acids Res..

[29]  Xin Lu,et al.  LC-MS-based metabonomics analysis. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  M. Elisaf,et al.  Gender‐related and age‐related urinalysis of healthy subjects by NMR‐based metabonomics , 2008, NMR in biomedicine.

[31]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[32]  John L Markley,et al.  Metabolite identification via the Madison Metabolomics Consortium Database , 2008, Nature Biotechnology.

[33]  Charlotte Schubert,et al.  Alterations in cerebral metabolomics and proteomic expression during sepsis. , 2007, Current neurovascular research.

[34]  Royston Goodacre,et al.  Metabolic fingerprinting as a diagnostic tool. , 2007, Pharmacogenomics.

[35]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[36]  Lyle Burton,et al.  Investigation of analytical variation in metabonomic analysis using liquid chromatography/mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[37]  Russ Greiner,et al.  Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. , 2007, Analytical chemistry.

[38]  Zheng Li,et al.  A Three Stage Integrative Pathway Search (TIPS©) framework to identify toxicity relevant genes and pathways , 2007, BMC Bioinformatics.

[39]  J. Nicholson,et al.  Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. , 2007, Analytical chemistry.

[40]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[41]  Ian D Wilson,et al.  Analytical strategies in metabonomics. , 2007, Journal of proteome research.

[42]  Ronald S. Tjeerdema,et al.  Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics , 2007, Metabolomics.

[43]  Joshua D. Knowles,et al.  Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics. , 2007, Analytical chemistry.

[44]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[45]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[46]  M. Rantalainen,et al.  OPLS discriminant analysis: combining the strengths of PLS‐DA and SIMCA classification , 2006 .

[47]  K. Alton,et al.  Application of mass spectrometry for metabolite identification. , 2006, Current drug metabolism.

[48]  Doris M Jacobs,et al.  Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. , 2006, Analytical biochemistry.

[49]  A. Feinberg,et al.  The emerging science of epigenomics. , 2006, Human molecular genetics.

[50]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[51]  J. Griffin The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[52]  I. Wilson,et al.  Metabolic phenotyping of nude and normal (Alpk:ApfCD, C57BL10J) mice. , 2006, Journal of proteome research.

[53]  Elaine Holmes,et al.  The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.

[54]  I. Wilson,et al.  A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.

[55]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[56]  J. Lindon,et al.  NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.

[57]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[58]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[59]  J. Trygg,et al.  Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. , 2005, Analytical chemistry.

[60]  Elaine Holmes,et al.  The challenges of modeling mammalian biocomplexity , 2004, Nature Biotechnology.

[61]  Philip W. Kuchel,et al.  Metabonomics Based on NMR Spectroscopy , 2004 .

[62]  D. Kell Metabolomics and systems biology: making sense of the soup. , 2004, Current opinion in microbiology.

[63]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[64]  T. Ebbels,et al.  Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. , 2004, Chemical research in toxicology.

[65]  Jeremy K Nicholson,et al.  An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. , 2004, Physiological genomics.

[66]  Ralf J. O. Torgrip,et al.  Peak alignment using reduced set mapping , 2003 .

[67]  J. Griffin,et al.  High‐resolution diffusion and relaxation‐edited magic angle spinning 1H NMR spectroscopy of intact liver tissue , 2003, Magnetic resonance in medicine.

[68]  M. Fink,et al.  IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[69]  I. Wilson,et al.  Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism , 2003, Nature Reviews Drug Discovery.

[70]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[71]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[72]  I. Wilson,et al.  Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS‐DA , 2002, FEBS letters.

[73]  T. Ebbels,et al.  Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. , 2002, Chemical research in toxicology.

[74]  J. Griffin,et al.  Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. , 2002, Analytical chemistry.

[75]  L. Magnotti,et al.  Influence of gut microflora on mesenteric lymph cytokine production in rats with hemorrhagic shock. , 2002, The Journal of trauma.

[76]  Erik Johansson,et al.  Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data. , 2002, The Analyst.

[77]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[78]  N. Reo NMR-BASED METABOLOMICS , 2002, Drug and chemical toxicology.

[79]  E Holmes,et al.  Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. , 2001, Analytical biochemistry.

[80]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[81]  J. Griffin,et al.  The biochemical profile of rat testicular tissue as measured by magic angle spinning 1H NMR spectroscopy , 2000, FEBS letters.

[82]  John C. Lindon,et al.  Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids , 2000 .

[83]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[84]  J. Macfie,et al.  Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity , 1999, Gut.

[85]  I. J. Fraser,et al.  A rapid and efficient approach to metabolite identification using nuclear magnetic resonance spectroscopy, liquid chromatography/mass spectrometry and liquid chromatography/nuclear magnetic resonance spectroscopy/sequential mass spectrometry , 1998 .

[86]  E Holmes,et al.  Development of a model for classification of toxin‐induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition , 1998, NMR in biomedicine.

[87]  E Holmes,et al.  Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.

[88]  C Zuppi,et al.  1H NMR spectra of normal urines: reference ranges of the major metabolites. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[89]  J C Lindon,et al.  Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. , 1994, Molecular pharmacology.

[90]  E Holmes,et al.  Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. , 1992, Molecular pharmacology.

[91]  J. Nicholson,et al.  Investigations into the biochemical effects of region-specific nephrotoxins. , 1989, Molecular pharmacology.

[92]  Rachel Cavill,et al.  Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.

[93]  Timothy M. D. Ebbels,et al.  Genetic algorithms for simultaneous variable and sample selection in metabonomics , 2009, Bioinform..

[94]  A. Zell,et al.  Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[95]  Huanwen Chen,et al.  Monitoring diet effects via biofluids and their implications for metabolomics studies. , 2007, Analytical chemistry.

[96]  Kazuhisa Yoshiya,et al.  Altered gut flora and environment in patients with severe SIRS. , 2006, The Journal of trauma.

[97]  Xiaohui Fan,et al.  Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[98]  J. Griffin,et al.  Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. , 2004, Current drug metabolism.

[99]  Elaine Holmes,et al.  Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.

[100]  Jeremy K. Nicholson,et al.  Global systems biology, personalized medicine and molecular epidemiology , 2006, Molecular systems biology.

[101]  P. Sajda,et al.  Bioinformatics Applications Note Hires—a Tool for Comprehensive Assessment and Interpretation of Metabolomic Data , 2022 .